a HF
Generic Name: divalproex sodium
Pill imprint a HF has been identified as Depakote ER 250 mg.
Depakote ER is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; hyperekplexia and belongs to the drug class fatty acid derivative anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Depakote ER 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Depakote ER Images
- Generic Name:
- divalproex sodium
- Imprint:
-
a HF
- Strength:
- 250 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
silicon dioxide
potassium sorbate
propylene glycol
titanium dioxide
polyethylene glycol
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-3826
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5525 | Physicians Total Care Inc (repackager) |
| 67544-0904 | Prepak Systems Inc (repackager) |
| 23490-7663 | Palmetto State Pharmaceuticals Inc (repackager) |
| 35356-0345 | Lake Erie Medical and Surgical Supply (repackager) |
| 49999-0941 | Lake Erie Medical and Surgical Supply (repackager) |
| 21695-0359 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Depakote ER resources
- Depakote ER Extended-Release Tablets (Wolters Kluwer)
- Depakote ER (Cerner Multum)
- Depakote ER (Micromedex) - Includes Dosage Information
- Depakote ER (FDA)
Search Again
